# Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea

> **NCT04829149** · — · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 5717 (actual)

## Conditions studied

- Dyslipidemias

## Interventions

- **OTHER:** Observational

## Key facts

- **NCT ID:** NCT04829149
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-14
- **Primary completion:** 2019-06-01
- **Final completion:** 2019-08-29
- **Target enrollment:** 5717 (ACTUAL)
- **Last updated:** 2021-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04829149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04829149, "Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04829149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*